Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i> from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025). [PDF]
Sader HS +4 more
europepmc +1 more source
Classification and applicability of new beta-lactamase inhibitors. [PDF]
Cercenado E, Candel FJ.
europepmc +1 more source
The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance. [PDF]
Simner PJ.
europepmc +1 more source
Emergence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae with Penicillin-Binding Protein 3 Insertions, Taiwan, 2021. [PDF]
Long T +6 more
europepmc +1 more source
Molecular and pharmacodynamic insights into β-lactam therapy for high-inoculum <i>Enterobacter cloacae</i> complex infections. [PDF]
Kunz Coyne AJ +6 more
europepmc +1 more source
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]
Sader HS +4 more
europepmc +1 more source
Spread of carbapenemase-producing <i>Serratia</i> spp. in France from 2016 to 2024: a comparative genomic study. [PDF]
Rezzoug I +8 more
europepmc +1 more source
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations. [PDF]
Sader HS +5 more
europepmc +1 more source
Description of a chromosomal <i>fosA6</i> tandem multicopy fragment and its <i>in vivo</i> evolution in consecutive KPC-producing <i>Klebsiella pneumoniae</i> clinical isolates. [PDF]
Mateo-Vargas MA +4 more
europepmc +1 more source
Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]
Candel FJ, Matesanz M.
europepmc +1 more source

